Sales of Covid-19 vaccine lift AstraZeneca’s first-quarter revenue to $7bn

PASCAL Soriot today launched an impassioned defence of AstraZeneca’s role in the fight against the pandemic as the FTSE100 drug-maker reported a leap in quarterly sales to more than $7billion (£5.25billion).